Burcon Nutrascience (T:BU) has notable insider buying

Johann Franz Tergesen, CEO, Director and Issuer or Subsidiary, acquired 56,000 Common Shares on a direct ownership basis at a price of $0.675 through the public market on July 4th, 2019. This represents a $37,800 investment into the company's shares and an account share holdings change of 5.5%.

Burcon Nutrascience is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Burcon NutraScience Corp (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates. The Company's products are targeted at the protein ingredient market and are particularly suited to health and wellness applications. The CLARISOY portfolio includes CLARISOY 100, 110, 120 and 150 for low potential of Hydrogen (pH) applications, and CLARISOY 170 and 180 for neutral applications. Peazazz is well-suited for use in low pH and neutral pH beverages, dairy alternative products, meal replacements, as well as a range of other healthy food and beverage product applications.